The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2016

Filed:

Jan. 18, 2011
Applicants:

Thomas T. Andersen, Albany, NY (US);

Herbert I. Jacobson, Albany, NY (US);

James A. Bennett, Delmar, NY (US);

Leroy Joseph, Albany, NY (US);

Alberto Bryan, Philadelphia, PA (US);

Inventors:

Thomas T. Andersen, Albany, NY (US);

Herbert I. Jacobson, Albany, NY (US);

James A. Bennett, Delmar, NY (US);

Leroy Joseph, Albany, NY (US);

Alberto Bryan, Philadelphia, PA (US);

Assignee:

ALBANY MEDICAL COLLEGE, Albany, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/52 (2006.01); C07K 7/64 (2006.01); A61K 38/00 (2006.01); A61K 38/12 (2006.01);
U.S. Cl.
CPC ...
C07K 7/52 (2013.01); C07K 7/64 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN] (SEQ ID NO: 13), AFPep, that has anti-estrotrophic activity. The analogs of the invention include peptides and peptidomimetics that inhibit estrogen receptor-dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.


Find Patent Forward Citations

Loading…